Balaji Amines Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Balaji Amines wird ein Gewinn- und Umsatzwachstum von 37.3% bzw. 16.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 37.3% pro Jahr wachsen soll.
Wichtige Informationen
37.3%
Wachstumsrate der Gewinne
37.3%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 20.8% |
| Wachstumsrate der Einnahmen | 16.8% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 09 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
The Balaji Amines Limited (NSE:BALAMINES) Analyst Just Cut Their Revenue Forecast By 15%
Aug 13
Balaji Amines Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 11At ₹2,409, Is It Time To Put Balaji Amines Limited (NSE:BALAMINES) On Your Watch List?
Jul 30Balaji Amines (NSE:BALAMINES) Is Increasing Its Dividend To ₹11.00
Jun 20Balaji Amines (NSE:BALAMINES) Has A Pretty Healthy Balance Sheet
Jun 12There Are Reasons To Feel Uneasy About Balaji Amines' (NSE:BALAMINES) Returns On Capital
Apr 05Downgrade: What You Need To Know About The Latest Balaji Amines Limited (NSE:BALAMINES) Forecasts
Feb 15Analysts Are More Bearish On Balaji Amines Limited (NSE:BALAMINES) Than They Used To Be
Nov 24Are Investors Undervaluing Balaji Amines Limited (NSE:BALAMINES) By 39%?
Jul 14Investors Shouldn't Overlook The Favourable Returns On Capital At Balaji Amines (NSE:BALAMINES)
Jun 22Balaji Amines' (NSE:BALAMINES) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09Is Now The Time To Look At Buying Balaji Amines Limited (NSE:BALAMINES)?
Apr 05Investors Shouldn't Overlook Balaji Amines' (NSE:BALAMINES) Impressive Returns On Capital
Mar 15These Analysts Think Balaji Amines Limited's (NSE:BALAMINES) Sales Are Under Threat
Feb 15With EPS Growth And More, Balaji Amines (NSE:BALAMINES) Makes An Interesting Case
Feb 08Balaji Amines (NSE:BALAMINES) Seems To Use Debt Quite Sensibly
Dec 25Why The 42% Return On Capital At Balaji Amines (NSE:BALAMINES) Should Have Your Attention
Dec 02Should You Think About Buying Balaji Amines Limited (NSE:BALAMINES) Now?
Oct 14Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Sep 27Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jul 13Is There Now An Opportunity In Balaji Amines Limited (NSE:BALAMINES)?
Jun 16The Trend Of High Returns At Balaji Amines (NSE:BALAMINES) Has Us Very Interested
May 06Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Apr 12We Think Balaji Amines (NSE:BALAMINES) Can Stay On Top Of Its Debt
Mar 28Should You Investigate Balaji Amines Limited (NSE:BALAMINES) At ₹2,901?
Mar 14Is Balaji Amines (NSE:BALAMINES) Using Too Much Debt?
Sep 28Does Balaji Amines (NSE:BALAMINES) Deserve A Spot On Your Watchlist?
Aug 23Is It Too Late To Consider Buying Balaji Amines Limited (NSE:BALAMINES)?
Jul 28Is Balaji Amines (NSE:BALAMINES) A Risky Investment?
Jun 25Here's Why I Think Balaji Amines (NSE:BALAMINES) Is An Interesting Stock
May 22Balaji Amines (NSE:BALAMINES) Might Become A Compounding Machine
May 01Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2026 | 20,871 | 3,873 | N/A | N/A | 1 |
| 3/31/2025 | 17,393 | 2,927 | N/A | N/A | 1 |
| 6/30/2024 | 15,626 | 1,954 | N/A | N/A | N/A |
| 3/31/2024 | 16,415 | 2,049 | -414 | 2,242 | N/A |
| 12/31/2023 | 16,990 | 1,842 | N/A | N/A | N/A |
| 9/30/2023 | 19,019 | 1,974 | 1,601 | 3,567 | N/A |
| 6/30/2023 | 21,489 | 2,553 | N/A | N/A | N/A |
| 3/31/2023 | 23,554 | 3,255 | 2,148 | 3,540 | N/A |
| 12/31/2022 | 26,652 | 3,868 | N/A | N/A | N/A |
| 9/30/2022 | 26,455 | 4,138 | 2,102 | 3,280 | N/A |
| 6/30/2022 | 25,433 | 4,010 | N/A | N/A | N/A |
| 3/31/2022 | 23,229 | 3,684 | 714 | 2,196 | N/A |
| 12/31/2021 | 19,598 | 3,442 | N/A | N/A | N/A |
| 9/30/2021 | 17,844 | 3,296 | -546 | 715 | N/A |
| 6/30/2021 | 15,411 | 2,956 | N/A | N/A | N/A |
| 3/31/2021 | 13,133 | 2,382 | -221 | 1,099 | N/A |
| 12/31/2020 | 11,592 | 1,845 | N/A | N/A | N/A |
| 9/30/2020 | 9,946 | 1,329 | 121 | 975 | N/A |
| 6/30/2020 | 9,395 | 1,186 | N/A | N/A | N/A |
| 3/31/2020 | 9,395 | 1,048 | 824 | 1,442 | N/A |
| 12/31/2019 | 9,095 | 1,000 | N/A | N/A | N/A |
| 9/30/2019 | 9,214 | 1,029 | -859 | 1,042 | N/A |
| 6/30/2019 | 9,319 | 1,036 | N/A | N/A | N/A |
| 3/31/2019 | 9,468 | 1,175 | -756 | 942 | N/A |
| 3/31/2018 | 8,644 | 1,132 | N/A | 1,400 | N/A |
| 3/31/2017 | 6,730 | 824 | N/A | 605 | N/A |
| 3/31/2016 | 6,446 | 576 | N/A | 848 | N/A |
| 3/31/2015 | 6,211 | 343 | N/A | 558 | N/A |
| 3/31/2014 | 6,121 | 335 | N/A | 1,106 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: BALAMINESDas prognostizierte Gewinnwachstum (31.8% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: BALAMINESDie Erträge des Unternehmens (31.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16% pro Jahr).
Hohe Wachstumserträge: BALAMINESEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: BALAMINESDie Einnahmen des Unternehmens (19.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.6% pro Jahr).
Hohe Wachstumseinnahmen: BALAMINESDie Einnahmen des Unternehmens (16.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von BALAMINES in 3 Jahren voraussichtlich hoch sein wird